Recordkeeping fees per participant
not reported
Not reported on this filing.
Employers › Vivos Therapeutics
Vivos Therapeutics 401(k)
- VVOS Nasdaq
- Health care and social assistance
- Littleton, CO
- EIN 81-3224056
- 1 plan with Schedule H financials
- Plan year 2024
- Vivos Therapeutics, Inc.
Administrative expenses excluding investment management, per participant · Vivos Therapeutics, Inc. 401(k) Plan · plan year 2024
$196.37
Higher than 77% of the 14,713 plans $1 to 10M that report it.
Source
= $23,957 / 122
derived, admin_expenses (2i(12)) minus invst_mgmt_fees (2i(5)), floored at 0; filing 20251014201717NAL0003582273001, received 2025-10-14
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20251014201717NAL0003582273001, received 2025-10-14
Percentiles compare this plan with the Schedule H plans $1 to 10M in assets of the same plan year, excluding final filings; shown only where at least 50 comparable plans report the figure. Plan year 2024-01-01 to 2024-12-31, filing received 2025-10-14.
Cost and contributions
Administrative expenses per participant
$196.37
Higher than 61% of the 15,210 plans $1 to 10M that report it.
Source
= $23,957 / 122
Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20251014201717NAL0003582273001, received 2025-10-14
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20251014201717NAL0003582273001, received 2025-10-14
Administrative expenses as a share of assets
1.422%
Higher than 95% of the 15,243 plans $1 to 10M that report it.
Source
= $23,957 / $1,684,728
Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20251014201717NAL0003582273001, received 2025-10-14
assets_eoy: Schedule H, Part I line 1f col (b); TOT_ASSETS_EOY_AMT pos 61; filing 20251014201717NAL0003582273001, received 2025-10-14
Employer contributions per participant
not reported
Not reported on this filing.
Employer share of total contributions
not reported
Not reported on this filing.
Plan terms, as stated in Vivos Therapeutics, Inc.'s SEC filings
Plan terms are described in Vivos Therapeutics, Inc.'s SEC filings: Form 10-K filed 2026-04-15. No term could be quoted from them with the required precision.
Plan features
2E profit-sharing · 2G fully participant-directed · 2F ERISA 404(c) plan · 2J 401(k) feature · 2S pre-approved plan document · 2T default investment (QDIA) · Form 5500, line 8a; TYPE_PENSION_BNFT_CODE pos 81; filing 20251014201717NAL0003582273001, received 2025-10-14
Full record, Vivos Therapeutics, Inc. 401(k) Plan
| Field | Value | Source |
|---|---|---|
| Plan sponsor | VIVOS THERAPEUTICS, INC. | Form 5500, Part II line 2a; SPONSOR_DFE_NAME pos 19; filing 20251014201717NAL0003582273001, received 2025-10-14 |
| Plan name | VIVOS THERAPEUTICS, INC. 401(K) PLAN | Form 5500, line 1a; PLAN_NAME pos 16; filing 20251014201717NAL0003582273001, received 2025-10-14 |
| Sponsor EIN / plan number | 81-3224056 / 001 | Form 5500, line 2b; SPONS_DFE_EIN pos 44; filing 20251014201717NAL0003582273001, received 2025-10-14 |
| Plan type | multiple-employer | Form 5500, Part I line A; TYPE_PLAN_ENTITY_CD pos 4; filing 20251014201717NAL0003582273001, received 2025-10-14 |
| Sponsor location | LITTLETON, CO | Form 5500, line 2a; SPONS_DFE_MAIL_US_STATE pos 25; filing 20251014201717NAL0003582273001, received 2025-10-14 |
| Industry (business code) | 621510, Health care and social assistance | Form 5500, line 2d; BUSINESS_CODE pos 46; filing 20251014201717NAL0003582273001, received 2025-10-14 |
| Plan year | 2024-01-01 to 2024-12-31 | Form 5500, Part I plan year; FORM_PLAN_YEAR_BEGIN_DATE pos 2; filing 20251014201717NAL0003582273001, received 2025-10-14 |
| Filing received | 2025-10-14 | Form 5500, EFAST2 receipt date; DATE_RECEIVED pos 102; filing 20251014201717NAL0003582273001, received 2025-10-14 |
| Final filing | no | Form 5500, Part I line B; FINAL_FILING_IND pos 8; filing 20251014201717NAL0003582273001, received 2025-10-14 |
| Amended filing | no | Form 5500, Part I line B; AMENDED_IND pos 7; filing 20251014201717NAL0003582273001, received 2025-10-14 |
| Participants, beginning of year | 147 | Form 5500, line 5; TOT_PARTCP_BOY_CNT pos 71; filing 20251014201717NAL0003582273001, received 2025-10-14 |
| Active participants | 113 | Form 5500, line 6a(2); TOT_ACTIVE_PARTCP_CNT pos 72; filing 20251014201717NAL0003582273001, received 2025-10-14 |
| Participants, end of year | 132 | Form 5500, line 6f; TOT_ACT_RTD_SEP_BENEF_CNT pos 77; filing 20251014201717NAL0003582273001, received 2025-10-14 |
| Participants with an account balance | 122 | Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20251014201717NAL0003582273001, received 2025-10-14 |
| Total assets, beginning of year | $1,573,528 | Schedule H, Part I line 1f col (a); TOT_ASSETS_BOY_AMT pos 30; filing 20251014201717NAL0003582273001, received 2025-10-14 |
| Total assets, end of year | $1,684,728 | Schedule H, Part I line 1f col (b); TOT_ASSETS_EOY_AMT pos 61; filing 20251014201717NAL0003582273001, received 2025-10-14 |
| Net assets, end of year | $1,684,728 | Schedule H, line 1l col (b); NET_ASSETS_EOY_AMT pos 67; filing 20251014201717NAL0003582273001, received 2025-10-14 |
| Total income | $575,506 | Schedule H, Part II line 2d; TOT_INCOME_AMT pos 97; filing 20251014201717NAL0003582273001, received 2025-10-14 |
| Net income | $111,200 | Schedule H, line 2k; NET_INCOME_AMT pos 111; filing 20251014201717NAL0003582273001, received 2025-10-14 |
| Participant contributions | $358,080 | Schedule H, line 2a(1)(B); PARTICIPANT_CONTRIB_AMT pos 69; filing 20251014201717NAL0003582273001, received 2025-10-14 |
| Other contributions (incl. rollovers) | $278 | Schedule H, line 2a(1)(C); OTH_CONTRIB_RCVD_AMT pos 70; filing 20251014201717NAL0003582273001, received 2025-10-14 |
| Total contributions | $358,358 | Schedule H, line 2a(3); TOT_CONTRIB_AMT pos 72; filing 20251014201717NAL0003582273001, received 2025-10-14 |
| Benefit payments | $440,349 | Schedule H, line 2e(4); TOT_DISTRIB_BNFT_AMT pos 101; filing 20251014201717NAL0003582273001, received 2025-10-14 |
| Total expenses (incl. benefit payments) | $464,306 | Schedule H, line 2j; TOT_EXPENSES_AMT pos 110; filing 20251014201717NAL0003582273001, received 2025-10-14 |
| Total administrative expenses | $23,957 | Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20251014201717NAL0003582273001, received 2025-10-14 |
| Contract administrator fees | $23,957 | Schedule H, line 2i(2); CONTRACT_ADMIN_FEES_AMT pos 106; filing 20251014201717NAL0003582273001, received 2025-10-14 |
| Administrative expenses excluding investment management | $23,957 | derived, admin_expenses (2i(12)) minus invst_mgmt_fees (2i(5)), floored at 0; filing 20251014201717NAL0003582273001, received 2025-10-14 |
| Held in mutual funds | $1,650,940 | Schedule H, line 1c(13) col (b); INT_REG_INVST_CO_EOY_AMT pos 55; filing 20251014201717NAL0003582273001, received 2025-10-14 |
| Independent auditor | PLANCHECK CPAS, LLC | Schedule H, Part III line 3a; ACCOUNTANT_FIRM_NAME pos 116; filing 20251014201717NAL0003582273001, received 2025-10-14 |
Position = column in the DOL layout for form year 2024. Filing 20251014201717NAL0003582273001, received 2025-10-14.
Service providers paid directly by the plan
| Provider | Relationship | Service codes | Direct compensation | Indirect |
|---|---|---|---|---|
| EMPOWER ANNUITY INSURANCE COMPANY Frecordkeeper | RECORDKEEPER | 64 Recordkeeping fees | $11,114 | yes |
| VANTAGE FINANCIAL GROUP, INC. | INVESTMENT ADVISOR | 27 Investment advisory (plan) | $9,190 | no |
| ASCENSUS HOLDINGS INC DBA FUTUREPLA | CONTRACT ADMIN | 13 Contract administrator | $1,808 | no |
Schedule C Part I line 2: name (a), service codes (b), relationship (c), direct compensation paid by the plan (d), indirect compensation received (e). Filing 20251014201717NAL0003582273001, received 2025-10-14.
What changed since the 2023 plan year
| Figure | 2023 | 2024 | Change |
|---|---|---|---|
| Total assets | $1,573,528 | $1,684,728 | 7.1% |
| Participants with a balance | 129 | 122 | -5.4% |
| Administrative expenses | $20,014 | $23,957 | 19.7% |
| Recordkeeping fees per participant | not reported | not reported | |
| Employer contributions | $144 | not reported |
Prior filing 20241012152250NAL0013441635001, received 2024-10-12; the plan years are contiguous.
Alerts, claims and corrections
Sponsor name as filed: VIVOS THERAPEUTICS, INC.; SEC registrant: Vivos Therapeutics, Inc. (CIK 1716166, matched by EIN).